Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 222,278 shares at $13.16 ($2.9M) on 2018-05-18, disclosed to the SEC on 2018-05-21.
Open-market sale of $2.9M CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 100,000 | $1.3M | 44.7% |
| 2 | $13.16 | 61,139 | $805K | 27.6% |
| 3 | $13.16 | 61,139 | $805K | 27.6% |
| Total | $13.10 avg | 222,278 | $2.9M | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |